Publications by authors named "Karin Hansen"

Claim this Profile
C
Clinical and molecular characteristics of 42 Danish patients with metastatic ALK fusion-positive lung cancer treated with first-line alectinib: A nationwide study.
Maiken Parm Ulhøi, Emma Roger Andersen, Christoffer Trier Maansson, Lars Munch Larsen, Miroslaw Stelmach, Karin Holmskov Hansen

Cancer Treat Res Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial.
Myung-Ju Ahn, Angelo Delmonte, Sharmistha Ghosh, Maximilian Hochmair, Tsung-Ying Yang, Karin Holmskov Hansen

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Clinical characteristics of Mycoplasma pneumoniae compared to Streptococcus pneumoniae in hospitalized adults with community-acquired pneumonia- a prospective study.
Karin Hansen, Lisa Wasserstrom, Jonas Ahl, Anna C Nilsson, Kristian Riesbeck

BMC Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics of Mycoplasma pneumoniae compared to Streptococcus pneumoniae in hospitalized adults with community-acquired pneumonia- a prospective study.
Karin Hansen, Lisa Wasserstrom, Jonas Ahl, Anna C Nilsson, Kristian Riesbeck

BMC Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote Symptom Monitoring of Patients With Advanced Lung Cancer (The ProWide Study): A Randomized Controlled Trial.
Rasmus Blechingberg Friis, Helle Pappot, Niels Henrik Hjollund, Tine McCulloch, Marianne Ingerslev Holt, Karin Holmskov Hansen

JCO Oncol Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence of radiologically verified community-acquired pneumonia requiring hospitalisation in adults living in southern Sweden, 2016-2018: a population-based study.
Elisabeth Rünow, Frida Valeur, Gustav Torisson, Karin Hansen, Christian Theilacker

BMC Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study.
Karin Holmskov Hansen, Maria Bibi Lyng, Annette Raskov Kodahl, Jon Thor Asmussen, Arman Arshad

BMC Med Genomics· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of Haemophilus influenzae in community-acquired pneumonia: an emerging pathogen in the elderly regardless of comorbidities compared to Streptococcus pneumoniae.
Linda Yamba Yamba, Karin Hansen, Lisa Wasserstrom, Yu-Ching Su, Jonas Ahl

Pneumonia (Nathan)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis.
Jon Lykkegaard Andersen, Jakob Sidenius Johansen, Edyta Maria Urbanska, Peter Meldgaard, Peter Hjorth-Hansen, Karin Holmskov Hansen

Lung Cancer Manag· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monkeypox virus-associated meningoencephalitis diagnosed by detection of intrathecal antibody production.
Hansen Karin, Båtshake Ylva, Söderholm Sandra, Pettke Aleksandra, Björkman Per

BMC Infect Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of + non-small cell lung cancer in Denmark.
Karin Holmskov Hansen, Jakob Sidenius Johansen, Edyta Maria Urbanska, Peter Meldgaard, Peter Hjorth-Hansen

Acta Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the microbial landscape: uncovering the pathogens associated with community-acquired pneumonia in hospitalized patients.
Karin Hansen, Linda Yamba Yamba, Lisa Wasserstrom, Elisabeth Rünow, Tommy Göransson

Front Public Health· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of patch age and size on forest soil characteristics in European agricultural landscapes.
Liping Wei, Jaan Liira, Steffen Ehrmann, Jonathan Lenoir, Guillaume Decocq, Karin Hansen

Sci Total Environ· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiographically confirmed community-acquired pneumonia in hospitalized adults due to pneumococcal vaccine serotypes in Sweden, 2016-2018-The ECAPS study.
Karin Hansen, Elisabeth Rünow, Gustav Torisson, Christian Theilacker, Andreas Palmborg

Front Public Health· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial.
Tina Kringelbach, Martin Højgaard, Kristoffer Rohrberg, Iben Spanggaard, Britt Elmedal Laursen, Karin Holmskov Hansen

BMC Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy.
Birgitte Bjørnhart, Charlotte Kristiansen, Jon Asmussen, Karin Holmskov Hansen, Kim Wedervang

Thromb Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory + NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials.
Scott N Gettinger, Rudolf M Huber, Dong-Wan Kim, Lyudmila Bazhenova, Karin Holmskov Hansen

JTO Clin Res Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osimertinib in non-small cell lung cancer with uncommon -mutations: a subgroup analysis with pooled data from two phase II clinical trials.
Inger Johanne Zwicky Eide, Simone Stensgaard, Åslaug Helland, Simon Ekman, Anders Mellemgaard, Karin Holmskov Hansen

Transl Lung Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study.
Mette T Mouritzen, Karen F Junker, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Karin H Hansen

Acta Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis.
Birgitte Bjørnhart, Karin Holmskov Hansen, Jon Thor Asmussen, Trine Lembrecht Jørgensen, Jørn Herrstedt

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of prophylactic cranial irradiation in patients with small cell lung cancer in the modern era of baseline magnetic resonance imaging of the brain.
Mads Kjaergaard Held, Olfred Hansen, Tine Schytte, Karin Holmskov Hansen, Rana Bahij

Acta Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial effect of osimertinib in relapsed -mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study.
Inger Johanne Zwicky Eide, Harald Grut, Åslaug Helland, Simon Ekman, Jens Benn Sørensen, Karin Holmskov Hansen

Acta Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study.
Fiona Blackhall, Kevin Jao, Laurent Greillier, Byoung Chul Cho, Konstantin Penkov, Karin Hansen

J Thorac Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy.
Mette T Mouritzen, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders W M Nielsen, Karin H Hansen

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to select cancer patients for immunotherapy.
Per Pfeiffer, Camilla Qvortrup, Karin Holmskov Hansen

EBioMedicine· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis